---
$id: https://graph.org.ai/products/commodity/51181605
$type: Product
source: UNSPSC
code: "51181605"
title: "Methimazole"
class: "51181600"
classTitle: "Thyroid and antithyroid drugs"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Methimazole

**UNSPSC Code**: 51181605
**Class**: [Thyroid and antithyroid drugs](Thyroid and antithyroid drugs.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antithyroid agent with the molecular formula C4H6N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 554Z48XN5E, chemically known as 1,3-dihydro-1-methyl-2h-imidazole-2-thione but generally known as methimazole, which bears US NIH Compound Identifier 1349907. European Medicines Agency schedules Thiamazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10967MIG. The term THIAMAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules methimazole in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, METHIMAZOLE remains the US FDA Preferred Term for this commodity. Methimazole bears US NLM identifiers UMLS ID C0025644 and NCI Concept Code C641. SMILES: S=C1N(CC[NH]1)C.

